RGEN
Price
$125.72
Change
-$0.83 (-0.66%)
Updated
Jun 5, 10:36 AM (EDT)
Capitalization
10.26B
61 days until earnings call
STXS
Price
$2.27
Change
-$0.02 (-0.87%)
Updated
Jun 5, 02:56 PM (EDT)
Capitalization
214.36M
63 days until earnings call
Interact to see
Advertisement

RGEN vs STXS

Header iconRGEN vs STXS Comparison
Open Charts RGEN vs STXSBanner chart's image
Repligen
Price$125.72
Change-$0.83 (-0.66%)
Volume$200
Capitalization10.26B
Stereotaxis
Price$2.27
Change-$0.02 (-0.87%)
Volume$220
Capitalization214.36M
RGEN vs STXS Comparison Chart
Loading...
RGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RGEN vs. STXS commentary
Jun 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGEN is a StrongBuy and STXS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 05, 2025
Stock price -- (RGEN: $126.55 vs. STXS: $2.29)
Brand notoriety: RGEN and STXS are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: RGEN: 66% vs. STXS: 41%
Market capitalization -- RGEN: $10.26B vs. STXS: $214.36M
RGEN [@Medical Specialties] is valued at $10.26B. STXS’s [@Medical Specialties] market capitalization is $214.36M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RGEN’s FA Score shows that 1 FA rating(s) are green whileSTXS’s FA Score has 0 green FA rating(s).

  • RGEN’s FA Score: 1 green, 4 red.
  • STXS’s FA Score: 0 green, 5 red.
According to our system of comparison, STXS is a better buy in the long-term than RGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RGEN’s TA Score shows that 4 TA indicator(s) are bullish while STXS’s TA Score has 5 bullish TA indicator(s).

  • RGEN’s TA Score: 4 bullish, 5 bearish.
  • STXS’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, STXS is a better buy in the short-term than RGEN.

Price Growth

RGEN (@Medical Specialties) experienced а +4.43% price change this week, while STXS (@Medical Specialties) price change was +9.05% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.90%. For the same industry, the average monthly price growth was +5.15%, and the average quarterly price growth was +1.32%.

Reported Earning Dates

RGEN is expected to report earnings on Aug 05, 2025.

STXS is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Medical Specialties (+0.90% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RGEN($10.3B) has a higher market cap than STXS($214M). STXS YTD gains are higher at: 0.439 vs. RGEN (-12.081). RGEN has higher annual earnings (EBITDA): 134M vs. STXS (-21.24M). RGEN has more cash in the bank: 751M vs. STXS (19.8M). STXS has less debt than RGEN: STXS (5.49M) vs RGEN (712M). RGEN has higher revenues than STXS: RGEN (639M) vs STXS (26.8M).
RGENSTXSRGEN / STXS
Capitalization10.3B214M4,813%
EBITDA134M-21.24M-631%
Gain YTD-12.0810.439-2,755%
P/E Ratio247.52N/A-
Revenue639M26.8M2,384%
Total Cash751M19.8M3,793%
Total Debt712M5.49M12,969%
FUNDAMENTALS RATINGS
RGEN vs STXS: Fundamental Ratings
RGEN
STXS
OUTLOOK RATING
1..100
523
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
92
Overvalued
PROFIT vs RISK RATING
1..100
97100
SMR RATING
1..100
9098
PRICE GROWTH RATING
1..100
8342
P/E GROWTH RATING
1..100
262
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

STXS's Valuation (92) in the Medical Specialties industry is in the same range as RGEN (95) in the Biotechnology industry. This means that STXS’s stock grew similarly to RGEN’s over the last 12 months.

RGEN's Profit vs Risk Rating (97) in the Biotechnology industry is in the same range as STXS (100) in the Medical Specialties industry. This means that RGEN’s stock grew similarly to STXS’s over the last 12 months.

RGEN's SMR Rating (90) in the Biotechnology industry is in the same range as STXS (98) in the Medical Specialties industry. This means that RGEN’s stock grew similarly to STXS’s over the last 12 months.

STXS's Price Growth Rating (42) in the Medical Specialties industry is somewhat better than the same rating for RGEN (83) in the Biotechnology industry. This means that STXS’s stock grew somewhat faster than RGEN’s over the last 12 months.

RGEN's P/E Growth Rating (2) in the Biotechnology industry is somewhat better than the same rating for STXS (62) in the Medical Specialties industry. This means that RGEN’s stock grew somewhat faster than STXS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RGENSTXS
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 3 days ago
76%
Declines
ODDS (%)
Bearish Trend 22 days ago
80%
Bearish Trend 15 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
RGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EILVX25.98N/A
N/A
Eaton Vance Large-Cap Value I
RYMKX50.48N/A
N/A
Rydex Russell 2000 1.5x Strategy H
IWTTX11.98N/A
N/A
Voya Global High Dividend Low Vol PortS2
INGFX35.00N/A
N/A
Invesco Oppenheimer International Gr R5
VYSGX14.15N/A
N/A
Voya Small Company W

RGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, RGEN has been closely correlated with DHR. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if RGEN jumps, then DHR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGEN
1D Price
Change %
RGEN100%
+1.73%
DHR - RGEN
66%
Closely correlated
+0.53%
A - RGEN
63%
Loosely correlated
+1.93%
BIO - RGEN
58%
Loosely correlated
+0.67%
BRKR - RGEN
58%
Loosely correlated
+1.15%
RVTY - RGEN
58%
Loosely correlated
+1.51%
More